Bytzer P. Talley N.J. Leemon M. Young L.J. Jones M.P. Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults Arch Intern Med. 2001 161 1989-1996 
Ricci J.A. Siddique R. Stewart W.F. Sandler R.S. Sloan S. Farup C.E. Upper gastrointestinal symptoms in a US national sample of adults with diabetes Scand J Gastroenterol. 2000 35 152-159 
Samsom M. Bharucha A. Gerich J.E. Diabetes mellitus and gastric emptying: questions and issues in clinical practice Diabetes Metab Res Rev. 2009 25 502-514 
Patrick A. Epstein O. Review article: gastroparesis Aliment Pharmacol Ther. 2008 27 724-740 
Frank J.W. Saslow S.B. Camilleri M. Thomforde G.M. Dinneen S. Rizza R.A. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus Gastroenterology 1995 109 755-765 
Intagliata N. Koch K.L. Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment Curr Gastroenterol Rep. 2007 9 270-279 
Barnett J.L. Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility Gastroenterology 1988 94 739-744 
Lysy J. Israeli E. Strauss-Liviatan N. Goldin E. Relationships between hypoglycaemia and gastric emptying abnormalities in insulin-treated diabetic patients Neurogastroenterol Motil. 2006 18 433-440 
Horowitz M. Jones K.L. Rayner C.K. Read N.W. &#8220;Gastric&#8221; hypoglycaemia &#8212; an important concept in diabetes management Neurogastroenterol Motil. 2006 18 405-407 
Ma J. Rayner C.K. Jones K.L. Horowitz M. Diabetic gastroparesis: diagnosis and management Drugs 2009 69 971-986 
Hejazi R. McCallum R. Diabetic gastroparesis: a review of medical treatments Pract Gastroenterol. 2009 6 10-20 
Forster J. Damjanov I. Lin Z. Sarosiek I. Wetzel P. McCallum R.W. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings J Gastrointest Surg. 2005 9 102-108 
Lin Z. Sarosiek I. Forster J. Damjanov I. Hou Q. McCallum R.W. Association of the status of interstitial cells of Cajal and electrogastrogram parameters, gastric emptying and symptoms in patients with gastroparesis Neurogastroenterol Motil. 2009 22 56-61 
Pasricha P.J. Pehlivanov N. Sugumar A. Jankovic J. Drug insight: from disturbed motility to disordered movement: a review of the clinical benefits and medicolegal risks of metoclopramide Nat Clin Pract Gastroenterol Hepatol. 2006 3 138-148 
Fraser R.J. Horowitz M. Maddox A.F. Harding P.E. Chatterton B.E. Dent J. Hyperglycaemia slows gastric emptying in type 1 (insulin.dependent) diabetes mellitus Diabetologia 1990 33 675-680 
Sogabe M. Okahisa T. Tsujigami K. Ultrasonographic assessment of gastric motility in diabetic gastroparesis before and after attaining glycemic control J Gastroenterol. 2005 40 583-590 
Schvarcz E. Palm&#233;r M. Aman J. Lindkvist B. Beckman K.W. Hypoglycaemia increases the gastric emptying rate in patients with type 1 diabetes mellitus Diabetic Med. 1993 10 660-663 
Schvarcz E. Palm&#233;r M. Aman J. Berne C. Hypoglycemia increases the gastric emptying rate in healthy subjects Diabetes Care 1995 18 674-676 
Miller G. Palmer K.R. Smith B. Ferrington C. Merrick M.V. Smoking delays gastric emptying of solids Gut 1989 30 50-53 
Jones K.L. Russo A. Stevens J.E. Wishart J.M. Berry M.K. Horowitz M. Predictors of delayed gastric emptying in diabetes Diabetes Care 2001 24 1264-1269 
Abell T.L. Camilleri M. Donohoe K. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine J Nucl Med Technol. 2008 36 44-54 
Eliasson B. Bj&#246;rnsson E. Urbanavicius V. Hyperinsulinaemia impairs gastrointestinal motility and slows carbohydrate absorption Diabetologia 1995 38 79-85 
Watkins C.C. Sawa A. Jaffrey S. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy J Clin Invest. 2000 106 373-384 
Bunck M.C. Diamant M. Corn&#233;r A. One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial Diabetes Care 2009 32 762-768 
Heine R.J. Gaal L.F. Johns D. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial Ann Intern Med. 2005 143 559-569 
Little T.J. Pilichiewicz A.N. Russo A. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses J Clin Endocrinol Metab. 2006 91 1916-1923 
Vella A. Lee J.S. Camilleri M. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus Neurogastroenterol Motil. 2002 14 123-131 
Samsom M. Szarka L.A. Camilleri M. Vella A. Zinsmeister A.R. Rizza R.A. Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition Am J Physiol Gastrointest Liver Physiol. 2000 278 946-951 
Koch C.A. Uwaifo G.I. Are gastrointestinal symptoms related to diabetes mellitus and glycemic control? Eur J Gastroenterol Hepatol. 2008 20 822-825 
Heine R.J. Brodows R. Diabetic gastroparesis N Engl J Med. 2007 357 418-420 
Longstreth G.F. Malagelada J.R. Kelly K.A. Metoclopramide stimulation of gastric motility and emptying in diabetic gastroparesis Ann Intern Med. 1977 86 195-196 
Perkel M.S. Moore C. Hersh T. Davidson E.D. Metoclopramide therapy in patients with delayed gastric emptying: a randomized, double-blind study Dig Dis Sci. 1979 24 662-666 
Peringer E. Jenner P. Marsden C.D. Effect of metoclopramide on turnover of brain dopamine noradrenaline and 5-hydroxytryptamine J Pharm Pharmacol. 1975 27 442-444 
Koch K. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and tretment Dig Dis Sci. 1999 44 1061-1075 
Schade R.R. Dugas M.C. Lhotsky D.M. Gavaler J.S. Thiel D.H. Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis Dig Dis Sci. 1985 30 10-15 
Erbas T. Varoglu E. Erbas B. Tastekin G. Akalin S. Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis Diabetes Care 1993 16 1511-1514 
McCallum R.W. Ricci D.A. Rakatansky H. A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis Diabetes Care 1983 6 463-467 
Ricci D.A. Saltzman M.B. Meyer C. Callachan C. McCallum R.W. Effect of metoclopramide in diabetic gastroparesis J Clin Gastroenterol. 1985 7 25-32 
Snape W.J. Jr. Battle W.M. Schwartz S.S. Braunstein S.N. Goldstein H.A. Alavi A. Metoclopramide to treat gastroparesis due to diabetes mellitus Ann Intern Med. 1982 96 444-446 
Talley N. Diabetic gastropathy and prokinetics Am J Gastroenterol. 2003 98 264-271 
Tonini M. Cipolina L. Poluuzzi E. Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics Aliment Pharmacol Ther. 2004 19 379-390 
Parkman H.P. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis Gastroenterology 2004 127 1592-1622 
Patterson D. Abell T. Rothstein R. Koch K. Barnett J. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis Am J Gastroenterol. 1999 94 1230-1234 
Farup C.E. Leidy N.K. Murray M. Williams G.R. Helbers L. Quigley E.M. Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis Diabetes Care 1998 21 1699-1706 
Heer M. Muller-Duysing W. Benes I. Diabetic gastroparesis: treatment with domperidone &#8212; a double-blind, placebo-controlled trial Digestion 1983 27 214-217 
Champion E.A. Domperidone (Motilium) improves symptoms and solid phase gastric emptying in diabetic gastroparesis Gastroenterol. 1987 82 975 
Dumitrascu D.L. Weinbeck M. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis Am J Gastroenterol. 2000 95 316-317 
Sugumar A. Singh A. Pasricha P.J. A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis Clin Gastroenterol Hepatol. 2008 6 726-733 
Camilleri M. Clinical practice. Diabetic gastroparesis N Engl J Med. 2007 356 820-829 
Richards R.D. Davenport K. McCallum R.W. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin Am J Gastroenterol. 1993 88 203-207 
Janssens J. Peeters T.L. Vantrappen G. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies N Engl J Med. 1990 322 1028-1031 
Dive A. Miesse C. Galanti L. Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: a double-blind, randomized, placebo-controlled study Crit Care Med. 1995 23 1356-1362 
Talley N.J. Verlinden M. Geenen D.J. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial Gut 2001 49 395-401 
Talley N.J. Verlinden M. Snape W. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial Aliment Pharmacol Ther. 2000 14 1653-1661 
McCallum R.W. Cynshi O. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis &#8212; a randomized, multicentre, placebo-controlled study Aliment Pharmacol Ther. 2007 26 1121-1130 
Hawkyard C.V. Koerner R.J. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks J Antimicrob Chemother. 2007 59 347-358 
McCallum R.W. Prakash C. Campoli-Richards D.M. Goa K.L. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal disorders Drugs 1988 36 652-681 
Champion M.C. Management of idiopathic, diabetic and miscellaneous gastroparesis with cisapride Scand J Gastroenterol Suppl. 1989 165 44-52 
Horowitz M. Maddern G.J. Maddox A. Wishart J. Chatterton B.E. Shearman D.J. Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis Gastroenterology 1987 93 311-315 
Horowitz M. Maddox A. Harding P.E. Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus Gastroenterology 1987 92 1899-1907 
McHugh S. Lico S. Diamant N.E. Cisapride vs. metoclopramide Dig Dis Sci. 1992 37 997-1001 
Havelund T. Oster-J&#248;rgensen E. Esh&#248;j O. Larsen M.L. Lauritsen K. Effects of cisapride on gastroparesis in patients with insulin-dependent diabetes mellitus Acta Medica Scandinavica 1987 222 339-343 
Takaya K. Ariyasu H. Kanamoto N. Ghrelin strongly stimulates growth hormone release in humans J Clin Endocrinol Metab. 2000 85 4908-4911 
Peino R. Baldelli R. Rodriguez-Garcia J. Ghrelin-induced growth hormone secretion in humans Eur J Endocrinol. 2000 143 R11-R14 
Date Y. Kojima M. Hosoda H. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans Endocrinology 2000 141 4255-4261 
Kojima M. Hosoda H. Date Y. Nakazato M. Matsuo H. Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 1999 402 656-660 
Howard A.D. Feighner S.D. Cully D.F. A receptor in pituitary and hypothalamus that functions in growth hormone release Science 1996 273 974-977 
Tack J. Depoortere I. Bisschops R. Influence of ghrelin on interdigestive gastrointestinal motility in humans Gut 2006 55 327-333 
Wren A.M. Seal L.J. Cohen M.A. Ghrelin enhances appetite and increases food intake in humans J Clin Endocrinol Metab. 2001 86 5992 
Druce M.R. Ghrelin increases food intake in obese as well as lean subjects Int J Obes (Lond). 2005 29 1130-1136 
Strasser F. Lutz T.A. Maeder M.T. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study Br J Cancer 2008 98 300-308 
Murray C.D. Martin N.M. Patterson M. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study Gut 2005 54 1693-1698 
Popescu I. Fleshner P.R. Pezzullo J.C. Charlton P.A. Kosutic G. Senagore A.J. The Ghrelin agonist TZP-101 for management of postoperative ileus after partial colectomy: a randomized, dose-ranging, placebo-controlled clinical trial Dis Colon Rectum 2010 53 126-134 
Ejskjaer N. Vestergaard E.T. Hellstr&#246;m P.M. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis Aliment Pharmacol Ther. 2009 29 1179-1187 
Lasseter K.C. Shaughnessy L. Cummings D. Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study J Clin Pharmacol. 2008 48 193-202 
Wang C.P. Kao C.H. Chen W.K. Lo W.Y. Hsieh C.L. A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis J Altern Complement Med. 2008 14 833-839 
Mearin F. Camilleri M. Malagelada J.R. Pyloric dysfunction in diabetics with recurrent nausea and vomiting Gastroenterology 1986 90 1919-1925 
Camilleri M. Brown M.L. Malagelada J.R. Relationship between impaired gastric emptying and abnormal gastrointestinal motility Gastroenterology 1986 91 94-99 
Jankovic J. Brin M.F. Therapeutic uses of botulinum toxin N Engl J Med. 1991 324 1186-1194 
Pehlivanov N. Pasricha P.J. Achalasia: botox, dilatation or laparoscopic surgery in 2006 Neurogastroenterol Motil. 2006 18 799-804 
Park M.I. Camilleri M. Gastroparesis: clinical update Am J Gastroenterol 2006 101 1129-1139 
Arts J. Holvoet L. Caenepeel P. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis Aliment Pharmacol Ther. 2007 26 1251-1258 
Friedenberg F.K. Palit A. Parkman H.P. Hanlon A. Nelson D.B. Botulinum toxin A for the treatment of delayed gastric emptying Am J Gastroenterol. 2008 103 416-423 
http://www.nice.org.uk/nicemedia/live/11130/31200/31200.pdf 
Anand C. Al-Juburi A. Familoni B. Gastric electrical stimulation is safe and effective: a long-term study in patients with drug-refractory gastroparesis in three regional centers Digestion 2007 75 83-89 
Abell T.L. Malinowski S. Minocha A. Nutrition aspects of gastroparesis and therapies for drug-refractory patients Nutr Clin Pract. 2006 21 23-33 
Cutts T.F. Luo J. Starkebaum W. Rashed H. Abell T.L. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Neurogastroenterol Motil. 2005 17 35-43 
Maranki J. Parkman H.P. Gastric electric stimulation for the treatment of gastroparesis Curr Gastroenterol Rep. 2007 9 286-294 
Maranki J.L. Lytes V. Meilahn J.E. Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis Dig Dis Sci. 2008 53 2072-2078 
Jones M.P. Maganti K. A systematic review of surgical therapy for gastroparesis Am J Gastroenterol. 2003 98 2122-2129 
